Clinical Trial Update: Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy trial of AzaSite for blepharitis has completed, assessing safety and efficacy in affected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 4 | Status: COMPLETED